Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Hulstaert

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
International Journal of Technology Assessment in Health Care|September 18, 2012
Pre-market clinical evaluations of innovative high-risk medical devices in EuropeFrank Hulstaert, Mattias Neyt, Imgard Vinck, et al.
Hepatology (Baltimore, Md.)|October 28, 2003
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis CFrederik Nevens, Tania Roskams, Hans Van Vlierberghe, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Performance characteristics of updated INNO-LiPA assays for molecular typing of human leukocyte antigen A (HLA-A), HLA-B, and HLA-DQB1 allelesKaren De Vreese, Rachel Barylski, Fiona Pughe, et al.
Clinical Chemistry and Laboratory Medicine|December 14, 2006
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodiesHugo Vanderstichele, Karen De Vreese, Kaj Blennow, et al.
Contemporary Clinical Trials|November 2, 2020
Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European countryGeert Molenberghs, Marc Buyse, Steven Abrams, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2023
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of CancerRobbe Saesen, Mieke Van Hemelrijck, Jan Bogaerts, et al.
The Lancet. Oncology|May 3, 2025
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of CancerFábio Cardoso Borges, Winette T A van der Graaf, Robbe Saesen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 30, 2004
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring systemRainer Ziermann, Linda Celis, Inge Derdelinckx, et al.
The Lancet. Respiratory Medicine|November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialJozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of Technology Assessment in Health Care|September 18, 2012
Pre-market clinical evaluations of innovative high-risk medical devices in EuropeFrank Hulstaert, Mattias Neyt, Imgard Vinck, et al.
Hepatology (Baltimore, Md.)|October 28, 2003
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis CFrederik Nevens, Tania Roskams, Hans Van Vlierberghe, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Performance characteristics of updated INNO-LiPA assays for molecular typing of human leukocyte antigen A (HLA-A), HLA-B, and HLA-DQB1 allelesKaren De Vreese, Rachel Barylski, Fiona Pughe, et al.
Clinical Chemistry and Laboratory Medicine|December 14, 2006
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodiesHugo Vanderstichele, Karen De Vreese, Kaj Blennow, et al.
Contemporary Clinical Trials|November 2, 2020
Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European countryGeert Molenberghs, Marc Buyse, Steven Abrams, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2023
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of CancerRobbe Saesen, Mieke Van Hemelrijck, Jan Bogaerts, et al.
The Lancet. Oncology|May 3, 2025
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of CancerFábio Cardoso Borges, Winette T A van der Graaf, Robbe Saesen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 30, 2004
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring systemRainer Ziermann, Linda Celis, Inge Derdelinckx, et al.
The Lancet. Respiratory Medicine|November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialJozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Pageof 4